HCA
AVNS icon

Harbor Capital Advisors’s Avanos Medical AVNS Stock Holding History

Harbor Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,567
Closed -$310K – 1241
2025
Q4 		$310K Sell
27,567
-504
-2% -$5.77K 0.02% 575
2025
Q3 		$325K Sell
28,071
-535
-2% -$6.26K 0.03% 562
2025
Q2 		$350K Sell
28,606
-223
-0.8% -$2.8K 0.01% 562
2025
Q1 		$413K Buy
28,829
+28,630
+14,387% +$447K 0.02% 555
2024
Q4 		$3K Buy
199
+60
+43% +$1.19K ﹤0.01% 1215
2024
Q3 		$3K Buy
+139
New +$3.18K ﹤0.01% 1208

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Harbor Capital Advisors's AVNS Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 27,567 shares — an estimated $310K sold.

Harbor Capital Advisors first reported a position in AVNS in Q3 2024 and held it in 6 quarters. The position peaked at $413K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 27,567 Avanos Medical shares in Q1 2026, an estimated $310K.
  • Harbor Capital Advisors first reported a position in Avanos Medical in Q3 2024 and held it in 6 quarters.
  • Harbor Capital Advisors's Avanos Medical position peaked at $413K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.